These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24034512)

  • 1. Daily glycaemic variability: benefits of optimal control.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():1-2. PubMed ID: 24034512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

  • 3. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which patients should be evaluated for blood glucose variability?
    Candido R
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the older hypoglycemic agents in type 2 diabetes therapy.
    Cao M; Bloomgarden Z
    J Diabetes; 2020 Nov; 12(11):844-847. PubMed ID: 32767624
    [No Abstract]   [Full Text] [Related]  

  • 6. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 8. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus?
    Zenari L; Marangoni A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():17-25. PubMed ID: 24034516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycemic control and cardiovascular benefit: what do we know today?].
    Egidi G; Popert U
    Dtsch Med Wochenschr; 2011 May; 136(19):1027; author reply 1027-8. PubMed ID: 21544796
    [No Abstract]   [Full Text] [Related]  

  • 11. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 12. The glycaemic sixer [glycaemic hexad].
    Kalra S
    J Pak Med Assoc; 2018 Oct; 68(10):1541-1542. PubMed ID: 30317360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes in the frail elderly: individualization of glycemic management.
    Laubscher T; Regier L; Bareham J
    Can Fam Physician; 2012 May; 58(5):543-6. PubMed ID: 22586198
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cardiologist's view of hypoglycemia.
    Nandish S; Wyatt J; Oliveros R; Zion AS; Lujan M; Chilton R
    Curr Atheroscler Rep; 2010 Mar; 12(2):88-95. PubMed ID: 20425243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 18. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 19. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.